Subscribe now

Health

mRNA cancer therapy now in human trials after shrinking mouse tumours

By Alice Klein

8 September 2021

mRNA bound to RNA binding protein

Molecular model of messenger RNA (pink) complexed with an RNA binding protein (light blue)

LAGUNA DESIGN/SCIENCE PHOTO LIBRARY

A cancer treatment that uses messenger RNA to launch an immune attack on cancer cells can completely shrink tumours in mice and is now being tested in people.

Messenger RNAs – or mRNAs – are molecules that instruct cells to make proteins. They have risen to fame with the roll out of mRNA covid-19 vaccines.

BioNTech, the German company that developed Pfizer’s mRNA covid-19 vaccine, is now testing whether mRNAs can be used to treat cancer by stimulating cells to produce…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox! We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

View introductory offers

No commitment, cancel anytime*

Offer ends 2nd of July 2024.

*Cancel anytime within 14 days of payment to receive a refund on unserved issues.

Inclusive of applicable taxes (VAT)

or

Existing subscribers

Sign in to your account